All tenders
75F40120C00150
FDABAA -20-00123 ROBUST IN VITRO/IN SILICO MODEL TO ACCELERATE GENERIC DRUG PRODUCT DEVELOPMENT FOR THE ORAL CAVITY ROUTE OF ADMINISTRATION
Food and Drug Administration · United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedEducation & TrainingFederal
Basic information
- Reference number
- 75F40120C00150
- Issuing organization
- Food and Drug Administration · Find award history →
- Government level
- Federal
- Solicitation type
- Education & Training
- Title
- FDABAA -20-00123 ROBUST IN VITRO/IN SILICO MODEL TO ACCELERATE GENERIC DRUG PRODUCT DEVELOPMENT FOR THE ORAL CAVITY ROUTE OF ADMINISTRATION
- Source
- USASpending (Federal)
- Source ID
- usa-75F40120C00150
Details
- Location
- United States
Description
FDABAA -20-00123 ROBUST IN VITRO/IN SILICO MODEL TO ACCELERATE GENERIC DRUG PRODUCT DEVELOPMENT FOR THE ORAL CAVITY ROUTE OF ADMINISTRATION Awarded to: UNIVERSITY OF HEALTH SCIENCES AND PHARMACY IN ST. LOUIS Agency: Department of Health and Human Services Sub-agency: Food and Drug Administration Award type: DEFINITIVE CONTRACT
Dates
- Publication
- 2020/09/28 12:00:00 AM UTC
- Closing date
- 2025/06/29 12:00:00 AM UTC
Estimated value
$1.2M USD
Classification
Normalized category
Education & Training